Sun Pharm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Thanks to a new way of accounting. 8 00 a. M. Across the emirates. Im Tracy Alloway in dubai. E welcome to Bloomberg Markets middle east. The oil surprise that saudi it looksistered like maybe we are now near overbought territory. Tracy thats exactly right. I thought they would bring a little pessimism entire tuesday show this morning, a little bit of a reality check and some technical analysis. Take a look at this chart. This shows the price of oil, the white line, but more interesting for our purposes is the white line on the bottom half of the screen. That is the relative value index, a tec...

Ganirelix Market | Ambinter, BLD Pharm, Chemenu

Case Name: Orexo AB v. Sun Pharm. Indus. Ltd., Civ. No. 20-12588 (GC/DEA), 2023 WL 4492095 (D.N.J. July 12, 2023) (Castner, J.) - Drug Product and Patent(s)-in-Suit: Zubsolv®...

As the generic Adderall shortage extends to Vyvanse and Ritalin, DEA and drug manufacturers trade blame for the ADHD medication shortfall.

On August 22, 2023, the U.S. Court of Appeals for the Federal Circuit issued yet another decision reinforcing what can only be described as the “lead compound” rule for challenging pharmaceutical and other chemical compound patents on the basis of obviousness.